MCK Stock's Uptrend Likely to Continue After Core Ventures AcquisitionZacks Investment Research • 08/27/24
Drug distributor McKesson to buy controlling stake in Core Ventures for about $2.5 blnReuters • 08/26/24
McKesson to acquire controlling stake in Core Ventures for $2.49 billion in cashMarket Watch • 08/26/24
McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute's Core VenturesBusiness Wire • 08/26/24
McKesson Reports Weak Sales, Joins JFrog, Fastly, Warner Bros. Discovery And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionBenzinga • 08/08/24
McKesson (MCK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 07/31/24